Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
WAIKOLOA, Hawaii — Geographic atrophy is a growing worldwide health issue, with approximately 8 million patients impacted, according to a speaker.
At Retina 2026, Healio | OSN associate medical editor Rishi P. Singh, MD, FASRS, delivered an expansive update on the GA treatment landscape.
“GA is a progressive disease. About 1.6 years after diagnosis, 67% of patients lose their ability to drive,” he said. “Within 2 years of diagnosis, a huge percentage of these patients lose two lines of vision.”
Additionally, 77% of patients report that GA affected their vision faster than expected after being